Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$216.19 USD
+5.31 (2.52%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $216.24 +0.05 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Brokerage Reports
Charles River Laboratories International, Inc. [CRL]
Reports for Purchase
Showing records 321 - 340 ( 384 total )
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Investing for the Future; Raising PT to $140
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
2018 Investor Day Lays Out Medium-Term Growth Roadmap
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Organic Growth Outlook Improving; Increasing PT to $126
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Initiating Coverage on Charles River Laboratories with a Neutral Rating and $115 PT
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS